Adial Pharmaceuticals, Inc share price logo

Adial Pharmaceuticals, Inc

NASDAQ: ADIL

Small Cap

$2.77

+0.02

(+0.91%)

Live

as on

Adial Pharmaceuticals, Inc Stock Performance

as on June 19, 2026 at 1:14 am IST

  • Day's Low

    Day's High

    $2.75
    $2.86
    downward going graph

    0.72%

    Downside

    3.25%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.31
    $18.90
    downward going graph

    52.71%

    Downside

    582.31%

    Upside

    downward going graph

Adial Pharmaceuticals, Inc share price movements today

Previous Close
$2.75
Open
$2.79
Volume
28.1K
Day's Low - High
$2.75 - $2.86
52 Week Low - High
$1.31 - $18.90

Adial Pharmaceuticals, Inc Historical Returns

1 Month Return
+ 70.81 %
3 Month Return
+ 61.76 %
1 Year Return
-53.97 %
3 Year Return
-98.18 %
5 Year Return
-99.85 %

Adial Pharmaceuticals, Inc Stock Fundamentals & Key Indicators

Check Adial Pharmaceuticals, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.2M

EPS (TTM)

-3.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.7M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-265.94%

Adial Pharmaceuticals, Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adial Pharmaceuticals, Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$6.2M-99.85%NA0.00%NA
BUY$37.6B59.83%71.0112.55%NA
BUY$115.0B144.34%26.8835.51%NA
BUY$64.4B13.01%15.0229.65%0.58%

Stock Returns calculator for Adial Pharmaceuticals, Inc Stock including INR - Dollar returns

The Adial Pharmaceuticals, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Adial Pharmaceuticals, Inc investment value today

Current value as on today

₹50,636

Returns

-₹49,364

(-49.36%)

Returns from Adial Pharmaceuticals, Inc Stock

-₹53,601 (-53.6%)

Dollar Impact

₹4,237 (+4.24%)

Analyst Recommendation on Adial Pharmaceuticals, Inc Stock

Based on 9 analysts

BUY

77.78%

Buy

22.22%

Hold

0.00%

Sell

Based on 9 analysts, 77.78% of analysts recommend a 'BUY' rating for Adial Pharmaceuticals, Inc. Average target price of $8

Adial Pharmaceuticals, Inc Share Price Target

Get share price movements and forecasts by analysts on Adial Pharmaceuticals, Inc.

What analysts predicted

65.38%UPSIDE

Target Price

$8

Current Price

$2.77

Analyzed by

9 Analysts

Target

$8.00

Adial Pharmaceuticals, Inc target price $8, a slight upside of 65.38% compared to current price of $2.77. According to 9 analysts rating.

Indian Investors' Interest in Adial Pharmaceuticals, Inc Stock

Search interest for Adial Pharmaceuticals, Inc Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:29% versus previous 30 day period

Adial Pharmaceuticals, Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
0
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-1
-1
-2
-2
-1
-2
-1
-1
-1
-2
EBITDA
-1
-6
-2
-2
-2
-2
-1
-1
-1
-2
Interest Expense
-
0
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-6
-2
-2
-2
-2
-1
-1
-1
-2
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-1
-6
-2
-2
-2
-2
-1
-1
-1
-2
Net Profit Margin
0.00%
-20084.85%
0.00%
0.00%
-367161.35%
0.00%
0.00%
0.00%
0.00%
0.00%

Adial Pharmaceuticals, Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
0
-6
-8
-10
-19
-10
-6
-8
-7
EBITDA
0
0
-6
-8
-10
-17
-10
-7
-13
-7
Interest Expense
0
0
1
-
-
3
0
-
-
-
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
0
-1
-11
-8
-10
-19
-10
-7
-13
-7
Income Tax Expense
0
0
-3
0
0
0
0
-1
-
-
Net Income
0
-1
-11
-8
-10
-19
-12
-7
-13
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Adial Pharmaceuticals, Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-6
-2
-2
-2
-2
-1
-1
-1
-2
Operating Cash Flow
-1
-2
-1
-1
-1
-1
-1
-1
-1
Investing Cash Flow
0
-
-
-
0
-
-
-
-
Financing Cash Flow
3
0
3
-
0
5
0
2
0
Change in Cash
2
-1
1
-1
-1
3
-1
1
-1

Adial Pharmaceuticals, Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-11
-8
-10
-19
-12
-7
-13
-7
Operating Cash Flow
0
-2
-6
-7
-11
-11
-6
-6
-6
Investing Cash Flow
0
0
0
0
0
-
1
-
0
Financing Cash Flow
0
6
9
5
13
9
4
7
8
Change in Cash
0
3
2
-2
1
-2
-1
0
2

Global Institutional Holdings in Adial Pharmaceuticals, Inc

Funds
Holdings
Renaissance Technologies Corp
0%
BlackRock Inc
0.05%
HARBOUR INVESTMENTS, INC.
0%
Northern Trust Corp
0%
Private Management Group Inc
0%

Adial Pharmaceuticals, Inc News & Key Events

    Insights on Adial Pharmaceuticals, Inc

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, ADIL stock has moved up by 70.8%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 18.4% return, outperforming this stock by 72.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Adial Pharmaceuticals, Inc Common Stock has experienced a drawdown of -98.2%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 75.8%

    About Adial Pharmaceuticals, Inc

    Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
    OrganisationAdial Pharmaceuticals, Inc
    Headquarters4870 Sadler Road, Glen Allen, VA, United States, 23060
    IndustryBiotechnology
    CEOMr. Cary John Claiborne MBA
    E-voting on sharesClick here to vote

    Key Management of Adial Pharmaceuticals, Inc

    Name

    Title

    Mr. Cary John Claiborne MBA

    CEO, President & Director

    Mr. Vinay Shah A.C.A., C.P.A., M.B.A.

    CFO & Treasurer

    Mr. Abel Svitavsky CPA

    Controller

    FAQs

    What is Adial Pharmaceuticals, Inc share price today?

    Adial Pharmaceuticals, Inc share price today is $2.77 as on . Adial Pharmaceuticals, Inc share today touched a day high of $2.86 and a low of $2.75.

    What is the 52 week high and 52 week low for Adial Pharmaceuticals, Inc share?

    Adial Pharmaceuticals, Inc share touched a 52 week high of $18.9 on and a 52 week low of $1.31 on . Adial Pharmaceuticals, Inc stock price today i.e. is trending at $2.77,which is 85.34% down from its 52 week high and 111.45% up from its 52 week low.

    What is Adial Pharmaceuticals, Inc's market capitalisation today?

    Adial Pharmaceuticals, Inc market capitalisation is $0.00T as on .

    How to invest in Adial Pharmaceuticals, Inc Stock (ADIL) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Adial Pharmaceuticals, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adial Pharmaceuticals, Inc Shares that will get you 0.5415 shares as per Adial Pharmaceuticals, Inc share price of $2.77 per share as on June 18, 2026 at 7:44 pm IST.

    What is the minimum amount required to buy Adial Pharmaceuticals, Inc Stock (ADIL) from India?

    Indian investors can start investing in Adial Pharmaceuticals, Inc (ADIL) shares with as little as ₹94.323 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹943.23 in Adial Pharmaceuticals, Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Adial Pharmaceuticals, Inc share’s latest price of $2.77 as on June 18, 2026 at 7:44 pm IST, you will get 3.6101 shares of Adial Pharmaceuticals, Inc. Learn more about fractional shares .

    What are the returns that Adial Pharmaceuticals, Inc has given to Indian investors in the last 5 years?

    Adial Pharmaceuticals, Inc stock has given -99.85% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?